BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23045544)

  • 1. Follow-up and timeliness after an abnormal cancer screening among underserved, urban women in a patient navigation program.
    Markossian TW; Darnell JS; Calhoun EA
    Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1691-700. PubMed ID: 23045544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boston Patient Navigation Research Program: the impact of navigation on time to diagnostic resolution after abnormal cancer screening.
    Battaglia TA; Bak SM; Heeren T; Chen CA; Kalish R; Tringale S; Taylor JO; Lottero B; Egan AP; Thakrar N; Freund KM
    Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1645-54. PubMed ID: 23045539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers to health care contribute to delays in follow-up among women with abnormal cancer screening: Data from the Patient Navigation Research Program.
    Ramachandran A; Snyder FR; Katz ML; Darnell JS; Dudley DJ; Patierno SR; Sanders MR; Valverde PA; Simon MA; Warren-Mears V; Battaglia TA;
    Cancer; 2015 Nov; 121(22):4016-24. PubMed ID: 26385420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient navigation improves cancer diagnostic resolution: an individually randomized clinical trial in an underserved population.
    Raich PC; Whitley EM; Thorland W; Valverde P; Fairclough D;
    Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1629-38. PubMed ID: 23045537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient navigation to improve follow-up of abnormal mammograms among disadvantaged women.
    Percac-Lima S; Ashburner JM; McCarthy AM; Piawah S; Atlas SJ
    J Womens Health (Larchmt); 2015 Feb; 24(2):138-43. PubMed ID: 25522246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple barriers delay care among women with abnormal cancer screening despite patient navigation.
    Ramachandran A; Freund KM; Bak SM; Heeren TC; Chen CA; Battaglia TA
    J Womens Health (Larchmt); 2015 Jan; 24(1):30-6. PubMed ID: 25513858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient navigation and time to diagnostic resolution: results for a cluster randomized trial evaluating the efficacy of patient navigation among patients with breast cancer screening abnormalities, Tampa, FL.
    Lee JH; Fulp W; Wells KJ; Meade CD; Calcano E; Roetzheim R
    PLoS One; 2013; 8(9):e74542. PubMed ID: 24066145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Navigating Latinas with breast screen abnormalities to diagnosis: the Six Cities Study.
    Ramirez AG; PĂ©rez-Stable EJ; Penedo FJ; Talavera GA; Carrillo JE; Fernandez ME; Holden AE; Munoz E; San Miguel S; Gallion K
    Cancer; 2013 Apr; 119(7):1298-305. PubMed ID: 23233265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social service barriers delay care among women with abnormal cancer screening.
    Primeau SW; Freund KM; Ramachandran A; Bak SM; Heeren T; Chen CA; Morton S; Battaglia TA
    J Gen Intern Med; 2014 Jan; 29(1):169-75. PubMed ID: 24197626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of patient navigation on timely cancer care: the Patient Navigation Research Program.
    Freund KM; Battaglia TA; Calhoun E; Darnell JS; Dudley DJ; Fiscella K; Hare ML; LaVerda N; Lee JH; Levine P; Murray DM; Patierno SR; Raich PC; Roetzheim RG; Simon M; Snyder FR; Warren-Mears V; Whitley EM; Winters P; Young GS; Paskett ED;
    J Natl Cancer Inst; 2014 Jun; 106(6):dju115. PubMed ID: 24938303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating a bilingual patient navigation program for uninsured women with abnormal screening tests for breast and cervical cancer: implications for future navigator research.
    Simon MA; Tom LS; Nonzee NJ; Murphy KR; Endress R; Dong X; Feinglass J
    Am J Public Health; 2015 May; 105(5):e87-94. PubMed ID: 25713942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of an integrated framework for a breast cancer screening and navigation program for women from underresourced communities.
    Henderson V; Tossas-Milligan K; Martinez E; Williams B; Torres P; Mannan N; Green L; Thompson B; Winn R; Watson KS
    Cancer; 2020 May; 126 Suppl 10():2481-2493. PubMed ID: 32348565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient Navigation Improves Subsequent Breast Cancer Screening After a Noncancerous Result: Evidence from the Patient Navigation in Medically Underserved Areas Study.
    Molina Y; Kim SJ; Berrios N; Glassgow AE; San Miguel Y; Darnell JS; Pauls H; Vijayasiri G; Warnecke RB; Calhoun EA
    J Womens Health (Larchmt); 2018 Mar; 27(3):317-323. PubMed ID: 28933653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers reported among patients with breast and cervical abnormalities in the patient navigation research program: impact on timely care.
    Katz ML; Young GS; Reiter PL; Battaglia TA; Wells KJ; Sanders M; Simon M; Dudley DJ; Patierno SR; Paskett ED
    Womens Health Issues; 2014; 24(1):e155-62. PubMed ID: 24439942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of patient and navigator race and language concordance on care after cancer screening abnormalities.
    Charlot M; Santana MC; Chen CA; Bak S; Heeren TC; Battaglia TA; Egan AP; Kalish R; Freund KM
    Cancer; 2015 May; 121(9):1477-83. PubMed ID: 25565151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient Navigation for Comprehensive Cancer Screening in High-Risk Patients Using a Population-Based Health Information Technology System: A Randomized Clinical Trial.
    Percac-Lima S; Ashburner JM; Zai AH; Chang Y; Oo SA; Guimaraes E; Atlas SJ
    JAMA Intern Med; 2016 Jul; 176(7):930-7. PubMed ID: 27273602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of timely follow-up after abnormal cancer screening among women seeking care at urban community health centers.
    Battaglia TA; Santana MC; Bak S; Gokhale M; Lash TL; Ash AS; Kalish R; Tringale S; Taylor JO; Freund KM
    Cancer; 2010 Feb; 116(4):913-21. PubMed ID: 20052731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of a combined navigator/promotora approach for Hispanic women diagnosed with breast abnormalities.
    Dudley DJ; Drake J; Quinlan J; Holden A; Saegert P; Karnad A; Ramirez A
    Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1639-44. PubMed ID: 23045538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparison of Different Intensities of Patient Navigation After Abnormal Mammography.
    Glassgow AE; Molina Y; Kim S; Campbell RT; Darnell J; Calhoun EA
    Health Promot Pract; 2019 Nov; 20(6):914-921. PubMed ID: 29907079
    [No Abstract]   [Full Text] [Related]  

  • 20. Patient navigation significantly reduces delays in breast cancer diagnosis in the District of Columbia.
    Hoffman HJ; LaVerda NL; Young HA; Levine PH; Alexander LM; Brem R; Caicedo L; Eng-Wong J; Frederick W; Funderburk W; Huerta E; Swain S; Patierno SR
    Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1655-63. PubMed ID: 23045540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.